M. McLimont

1.3k total citations
18 papers, 1.0k citations indexed

About

M. McLimont is a scholar working on Hematology, Pediatrics, Perinatology and Child Health and Surgery. According to data from OpenAlex, M. McLimont has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 5 papers in Pediatrics, Perinatology and Child Health and 3 papers in Surgery. Recurrent topics in M. McLimont's work include Hemophilia Treatment and Research (11 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). M. McLimont is often cited by papers focused on Hemophilia Treatment and Research (11 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). M. McLimont collaborates with scholars based in Canada, United States and Sweden. M. McLimont's co-authors include Brian M. Feldman, Victor S. Blanchette, S M Hanly, Jack Greenblatt, N. Zourikian, Pamela Hilliard, Marijke van den Berg, Pia Petrini, Marilyn J. Manco‐Johnson and Sharon Funk and has published in prestigious journals such as Nature, Blood and Journal of Clinical Epidemiology.

In The Last Decade

M. McLimont

18 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. McLimont Canada 13 783 204 199 108 93 18 1.0k
Nicola J. Rowbotham United Kingdom 18 123 0.2× 101 0.5× 325 1.6× 78 0.7× 66 0.7× 45 862
Brenda Riske United States 16 582 0.7× 81 0.4× 75 0.4× 51 0.5× 27 0.3× 33 698
Edith S. Shear United States 13 579 0.7× 33 0.2× 80 0.4× 52 0.5× 95 1.0× 16 800
S. Ota Canada 10 138 0.2× 57 0.3× 42 0.2× 43 0.4× 39 0.4× 14 476
M. Angastiniotis Cyprus 16 680 0.9× 929 4.6× 72 0.4× 134 1.2× 68 0.7× 20 1.2k
Wendy Mills United Kingdom 9 183 0.2× 86 0.4× 43 0.2× 23 0.2× 31 0.3× 17 676
María Eva Mingot‐Castellano Spain 16 689 0.9× 192 0.9× 61 0.3× 38 0.4× 64 0.7× 74 874
R. H. T. Ward United Kingdom 16 159 0.2× 219 1.1× 88 0.4× 89 0.8× 117 1.3× 48 804
Katarzyna Derwich Poland 12 131 0.2× 45 0.2× 86 0.4× 28 0.3× 38 0.4× 70 550
Diana Milojevic United States 12 381 0.5× 15 0.1× 163 0.8× 40 0.4× 127 1.4× 24 579

Countries citing papers authored by M. McLimont

Since Specialization
Citations

This map shows the geographic impact of M. McLimont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. McLimont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. McLimont more than expected).

Fields of papers citing papers by M. McLimont

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. McLimont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. McLimont. The network helps show where M. McLimont may publish in the future.

Co-authorship network of co-authors of M. McLimont

This figure shows the co-authorship network connecting the top 25 collaborators of M. McLimont. A scholar is included among the top collaborators of M. McLimont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. McLimont. M. McLimont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Feldman, Brian M., Camille Achonu, Michelle Batthish, et al.. (2017). Proposed Core Set of Items for Measuring Disease Activity in Systemic Juvenile Idiopathic Arthritis. The Journal of Rheumatology. 45(1). 115–121. 5 indexed citations
2.
Stain, A. M., Anthony K.C. Chan, M. McLimont, et al.. (2015). Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS). Haemophilia. 21(4). 469–476. 11 indexed citations
3.
Abrahamyan, Lusine, Andrew R. Willan, Joseph Beyene, et al.. (2014). Using Value-of-Information Methods when the Disease Is Rare and the Treatment Is Expensive—The Example of Hemophilia A. Journal of General Internal Medicine. 29(S3). 767–773. 12 indexed citations
4.
Hilliard, Pamela, N. Zourikian, Victor S. Blanchette, et al.. (2013). Musculoskeletal health of subjects with hemophilia A treated with tailored prophylaxis: Canadian Hemophilia Primary Prophylaxis (CHPS) Study. Journal of Thrombosis and Haemostasis. 11(3). 460–466. 41 indexed citations
5.
Kraft, Jeannette, Victor S. Blanchette, Paul Babyn, et al.. (2012). Magnetic resonance imaging and joint outcomes in boys with severe hemophilia A treated with tailored primary prophylaxis in Canada. Journal of Thrombosis and Haemostasis. 10(12). 2494–2502. 73 indexed citations
6.
Anderson, Peter J., Alba Agostino, Meredith R. Golomb, et al.. (2011). Effect of intracranial bleeds on the neurocognitive, academic, behavioural and adaptive functioning of boys with haemophilia. Haemophilia. 18(2). 229–234. 14 indexed citations
7.
8.
Blanchette, Victor S., Georges E. Rivard, Mohan Pai, et al.. (2007). 10 Year Musculoskeletal Outcomes with Tailored Primary Prophylaxis: The Canadian Hemophilia Prophylaxis Study.. Blood. 110(11). 84–84. 2 indexed citations
9.
Feldman, Brian M., Menaka Pai, Georges‐Étienne Rivard, et al.. (2006). Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study. Journal of Thrombosis and Haemostasis. 4(6). 1228–1236. 192 indexed citations
10.
Hilliard, Pamela, Sharon Funk, N. Zourikian, et al.. (2006). Hemophilia joint health score reliability study. Haemophilia. 12(5). 518–525. 275 indexed citations
11.
Ota, S., M. McLimont, Manuel Carção, et al.. (2006). Definitions for haemophilia prophylaxis and its outcomes: The Canadian Consensus Study. Haemophilia. 13(1). 12–20. 43 indexed citations
12.
Ramanan, Athimalaipet V, Rayfel Schneider, Michelle Batthish, et al.. (2005). Developing a disease activity tool for systemic-onset juvenile idiopathic arthritis by international consensus using the Delphi approach. Lara D. Veeken. 44(12). 1574–1578. 17 indexed citations
13.
Feldman, B. M., Paul Babyn, Andréa S. Doria, et al.. (2005). Proceedings of the International Haemophilia Prophylaxis Study Group Meeting, November 2003, Montreal, PQ, Canada. Haemophilia. 11(1). 58–63. 8 indexed citations
14.
Lam, Catherine G., et al.. (2004). Revised versions of the Childhood Health Assessment Questionnaire (CHAQ) are more sensitive and suffer less from a ceiling effect. Arthritis Care & Research. 51(6). 881–889. 51 indexed citations
15.
Sung, Lillian, Nancy L. Young, Mark Greenberg, et al.. (2004). Health-related quality of life (HRQL) scores reported from parents and their children with chronic illness differed depending on utility elicitation method. Journal of Clinical Epidemiology. 57(11). 1161–1166. 56 indexed citations
16.
Sung, Lillian, Mark Greenberg, John Doyle, et al.. (2003). Construct validation of the Health Utilities Index and the Child Health Questionnaire in children undergoing cancer chemotherapy. British Journal of Cancer. 88(8). 1185–1190. 44 indexed citations
17.
Sung, Lillian, Michael Greenberg, Nancy L. Young, et al.. (2003). Validity of a modified standard gamble elicited from parents of a hospital-based cohort of children. Journal of Clinical Epidemiology. 56(9). 848–855. 9 indexed citations
18.
Greenblatt, Jack, M. McLimont, & S M Hanly. (1981). Termination of transcription by nusA gene protein of Escherichia coli. Nature. 292(5820). 215–220. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicola J. Rowbotham Breakdown of academic impact, for papers by Brenda Riske Breakdown of academic impact, for papers by Edith S. Shear Breakdown of academic impact, for papers by S. Ota Breakdown of academic impact, for papers by M. Angastiniotis Breakdown of academic impact, for papers by Wendy Mills Breakdown of academic impact, for papers by María Eva Mingot‐Castellano Breakdown of academic impact, for papers by R. H. T. Ward Breakdown of academic impact, for papers by Katarzyna Derwich Breakdown of academic impact, for papers by Diana Milojevic
Rankless by CCL
2026